NasdaqGM - Delayed Quote USD
Third Harmonic Bio, Inc. (THRD)
At close: 4:00 PM EST
After hours: 4:21 PM EST
Insider Purchases Last 6 Months
Shares | Transactions | |
---|---|---|
Purchases | 91,001 | 11 |
Sales | 1,072,799 | 9 |
Net Shares Purchased (Sold) | -981,798 | 20 |
Total Insider Shares Held | 4.08M | -- |
% Net Shares Purchased (Sold) | -19.40% | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
Shares | |
---|---|
Net Shares Purchased (Sold) | -- |
% Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
Insider | Transaction | Type | Value | Date |
---|---|---|---|---|
BVF PARTNERS L P Beneficial Owner of more than 10% of a Class of Security | Sale at price 14.30 per share. | Direct | 14,300,000 | Oct 29, 2024 |
CONNER EDWARD R Officer | Conversion of Exercise of derivative security at price 4.20 per share. | Direct | 11,227 | Oct 28, 2024 |
CONNER EDWARD R Officer | Sale at price 15.00 per share. | Direct | 40,095 | Oct 28, 2024 |
CONNER EDWARD R Officer | Conversion of Exercise of derivative security at price 4.20 per share. | Direct | 20,118 | Sep 19, 2024 |
PERSON JULIE Officer | Conversion of Exercise of derivative security at price 4.20 per share. | Direct | 42,000 | Sep 19, 2024 |
CONNER EDWARD R Officer | Sale at price 15.00 per share. | Direct | 71,850 | Sep 19, 2024 |
PERSON JULIE Officer | Sale at price 14.00 - 14.29 per share. | Direct | 142,727 | Sep 19, 2024 |
PERSON JULIE Officer | Conversion of Exercise of derivative security at price 4.20 per share. | Direct | 42,000 | Jun 26, 2024 |
PERSON JULIE Officer | Sale at price 12.46 per share. | Direct | 124,569 | Jun 26, 2024 |
DITTMAN JENNIFER Officer | Conversion of Exercise of derivative security at price 14.21 per share. | Direct | 7,020 | Jun 7, 2024 |
DITTMAN JENNIFER Officer | Sale at price 14.17 per share. | Direct | 7,000 | Jun 7, 2024 |
DITTMAN JENNIFER Officer | Stock Award(Grant) at price 14.21 per share. | Direct | 7,020 | Jun 7, 2024 |
DITTMAN JENNIFER Officer | Conversion of Exercise of derivative security at price 14.40 per share. | Direct | 15,005 | May 20, 2024 |
DITTMAN JENNIFER Officer | Sale at price 14.00 per share. | Direct | 14,588 | May 20, 2024 |
DITTMAN JENNIFER Officer | Stock Award(Grant) at price 14.40 per share. | Direct | 15,005 | May 20, 2024 |
DITTMAN JENNIFER Officer | Conversion of Exercise of derivative security at price 14.23 per share. | Direct | 237,157 | May 16, 2024 |
DITTMAN JENNIFER Officer | Sale at price 14.04 per share. | Direct | 331,066 | May 16, 2024 |
DITTMAN JENNIFER Officer | Stock Award(Grant) at price 14.23 per share. | Direct | 335,515 | May 16, 2024 |
HOLLES NATALIE C Chief Executive Officer | Conversion of Exercise of derivative security at price 4.20 per share. | Direct | 84,932 | May 9, 2024 |
HOLLES NATALIE C Chief Executive Officer | Sale at price 12.18 per share. | Direct | 246,300 | May 9, 2024 |
HOLLES NATALIE C Chief Executive Officer | Conversion of Exercise of derivative security at price 4.20 per share. | Direct | 56,944 | Apr 11, 2024 |
HOLLES NATALIE C Chief Executive Officer | Sale at price 12.19 per share. | Direct | 165,214 | Apr 11, 2024 |
PERSON JULIE Officer | Conversion of Exercise of derivative security at price 4.20 per share. | Direct | 4,649 | Apr 4, 2024 |
PERSON JULIE Officer | Sale at price 10.00 per share. | Direct | 11,070 | Apr 4, 2024 |
CONNER EDWARD R Officer | Conversion of Exercise of derivative security at price 4.20 per share. | Direct | 20,118 | Dec 5, 2023 |
PERSON JULIE Officer | Conversion of Exercise of derivative security at price 4.20 per share. | Direct | 54,025 | Dec 5, 2023 |
CONNER EDWARD R Officer | Sale at price 10.03 per share. | Direct | 48,062 | Dec 5, 2023 |
PERSON JULIE Officer | Sale at price 10.30 per share. | Direct | 132,484 | Dec 5, 2023 |
BVF PARTNERS L P Beneficial Owner of more than 10% of a Class of Security | Purchase at price 4.11 per share. | Indirect | 879,499 | Dec 20, 2022 |
Related Tickers
DNTH Dianthus Therapeutics, Inc.
29.41
+2.30%
COGT Cogent Biosciences, Inc.
10.48
+4.90%
MBX MBX Biosciences, Inc.
22.75
-1.34%
CRGX CARGO Therapeutics, Inc.
21.27
+3.76%
SYRE Spyre Therapeutics, Inc.
37.48
+4.34%
BCAX Bicara Therapeutics Inc.
23.77
-5.64%
CNTA Centessa Pharmaceuticals plc
15.99
-0.06%
AVBP ArriVent BioPharma, Inc.
34.91
+9.16%
TECX Tectonic Therapeutic, Inc.
44.85
+4.25%
TRDA Entrada Therapeutics, Inc.
18.66
+0.21%